A recent study analyzing the 60 human-cancer cell lines of the NCI Developmental Therapeutic Anticancer Screen (the NCI-60) found two lung-cancer cell lines that do not express the TDP1 protein because one has a homozygous deleterious mutation and the other has a hypermethylated promoter of the TDP1 gene13. This evidence concerns the gene TDP1 and lung cancer.